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Quarantine is for individuals who may have been exposed to someone who is COVID-19 positive but are not exhibiting any symptoms and have not tested 
positive. Individuals who are in quarantine should stay in place for 14 days. 
 
 
Isolation is for individuals who have either tested positive for COVID-19 or who are exhibiting symptoms of COVID-19 (including fever, chills, shaking chills, 
muscle pain, headache, sore throat, or new loss of taste or smell) and have been told by a provider that they have, or probably have, COVID-19, even in the 
absence of a test. 
Worker 
Type 
Quarantine for 14 
days when… 
Isolate when… End Isolation and Return to work when… 
Health 
Care 
Workers As of May 4, 2020, the 
CDC is not recommending 
that these workers self-
quarantine after an 
exposure if they are not 
experiencing COVID-19 
symptoms. All workers 
should wear appropriate 
PPE, and self-monitor for 
symptoms.  
 
You have tested 
positive for COVID-19 
OR  
you have symptoms 
of COVID-19 
Symptomatic 
 
1. Symptom-based strategy 
 
• At least 3 days (72 hours) have passed since recovery defined as resolution of fever 
without the use of fever-reducing medications and 
• Improvement in respiratory symptoms (e.g., cough, shortness of breath); and, 
• At least 10 days have passed since symptoms first appeared. 
2.  Test-based strategy:  
 
• Resolution of fever without the use of fever-reducing medications and 
• Improvement in respiratory symptoms (e.g., cough, shortness of breath), and 
• Negative results of two consecutive respiratory specimens collected ≥24 hours apart 
Asymptomatic 
 
1. Time-based strategy: At least 10 days have passed since the date of their first positive 
COVID-19 diagnostic test assuming they have not subsequently developed symptoms 
since their positive test.  
 
2. Test-based strategy: Negative results of two consecutive respiratory specimens collected 
≥24 hours apart 
*A positive test does not necessarily correlate with the person’s ability to transmit the disease 
First 
Responders 
Essential 
Workers 
All Other 
Workers 
You have been exposed to 
someone with COVID-19  
BUT  
you don’t have symptoms 
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Healthcare Personnel (HCP):  
Return to Work for Healthcare Personnel with Confirmed or Suspected COVID-19 
 
Ending Isolation/Return to Work Guidance 
 
Symptomatic HCP with suspected or confirmed COVID-19 
1. Symptom-based strategy. Exclude from work until: 
• At least 3 days (72 hours) have passed since recovery defined as resolution of fever without the use of fever-
reducing medications and improvement in respiratory symptoms (e.g., cough, shortness of breath); and, 
• At least 10 days have passed since symptoms first appeared 
2. Test-based strategy. Exclude from work until: 
• Resolution of fever without the use of fever-reducing medications and 
• Improvement in respiratory symptoms (e.g., cough, shortness of breath), and 
• Negative results of an FDA Emergency Use Authorized COVID-19 molecular assay for detection of SARS-CoV-2 
RNA from at least two consecutive nasopharyngeal swab specimens collected ≥24 hours apart (total of two 
negative specimens).  
• Note: there have been reports of prolonged detection of RNA without direct correlation to viral culture. 
HCP with laboratory-confirmed COVID-19 who have not had any symptoms 
1. Time-based strategy. Exclude from work until:  
• 10 days have passed since the date of their first positive COVID-19 diagnostic test assuming they have not 
subsequently developed symptoms since their positive test. If they develop symptoms, then the symptom-based 
or test-based strategy should be used.   
• Note: because symptoms cannot be used to gauge where these individuals are in the course of their illness, it is 
possible that the duration of viral shedding could be longer or shorter than 10 days after their first positive test. 
2. Test-based strategy. Exclude from work until:  
• Negative results of an FDA Emergency Use Authorized COVID-19 molecular assay for detection of SARS-CoV-2 
RNA from at least two consecutive nasopharyngeal swab specimens collected ≥24 hours apart (total of two 
negative specimens).  
• Note: because of the absence of symptoms, it is not possible to gauge where these individuals are in the course 
of their illness.  There have been reports of prolonged detection of RNA without direct correlation to viral 
culture. 
Note that detecting viral RNA via PCR does not necessarily mean that infectious virus is present. 
If HCP had COVID-19 ruled out and have an alternate diagnosis (e.g., tested positive for influenza), criteria for return to 
work should be based on that diagnosis. 
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Return to Work Practices and Work Restrictions 
 
After returning to work, HCP should: 
• Wear a facemask for source control at all times while in the healthcare facility until all symptoms are completely 
resolved or until 14 days after illness onset, whichever is longer. A facemask instead of a cloth face covering 
should be used by these HCP for source control during this time period while in the facility. After this time 
period, these HCP should revert to their facility policy regarding universal source control during the pandemic. 
‒ A facemask for source control does not replace the need to wear an N95 or higher-level respirator (or 
other recommended PPE) when indicated, including when caring for patients with suspected or 
confirmed COVID-19. 
‒ Of note, N95 or other respirators with an exhaust valve might not provide source control. 
• HCP should be restricted from contact with severely immunocompromised patients (e.g., transplant, 
hematology-oncology) until 14 days after illness onset 
• HCP should self-monitor for symptoms, and seek re-evaluation from occupational health if respiratory 
symptoms recur or worsen 
 
Employers should not require a positive COVID-19 test result or a healthcare provider’s note 
for employees who are sick to validate their illness, qualify for sick leave, or to return to 
work.  
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At-work Exposure 
 
Interim U.S. Guidance for Risk Assessment and Public Health Management of Healthcare Personnel with Potential 
Exposure in a Healthcare Setting to Patients with Coronavirus Disease 2019 (COVID-19) 
I. Definitions: 
 
Self-monitoring means HCP should monitor themselves for fever by taking their temperature twice a day and remain 
alert for symptoms of COVID-19 (e.g., cough, shortness of breath, sore throat, myalgias, malaise). Anyone on self-
monitoring should be provided a plan for whom to contact if they develop fever or respiratory symptoms during the self-
monitoring period to determine whether medical evaluation is needed. 
Active monitoring means that the state or local public health authority assumes responsibility for establishing regular 
communication with potentially exposed people to assess for the presence of fever or symptoms of COVID-19 (e.g., 
cough, shortness of breath, sore throat, myalgias, malaise*. For HCP with high- or medium-risk exposures, CDC 
recommends this communication occurs at least once each day. The mode of communication can be determined by the 
state or local public health authority and may include telephone calls or any electronic or internet-based means of 
communication. 
For HCP, active monitoring can be delegated by the health department to the HCP’s healthcare facility occupational 
health or infection control program, if both the health department and the facility are in agreement. Note, inter-
jurisdictional coordination will be needed if HCP live in a different local health jurisdiction than where the healthcare 
facility is located. 
Self-Monitoring with delegated supervision in a healthcare setting means HCP perform self-monitoring with oversight 
by their healthcare facility’s occupational health or infection control program in coordination with the health 
department of jurisdiction, if both the health department and the facility are in agreement. On days HCP are scheduled 
to work, healthcare facilities could consider measuring temperature and assessing symptoms prior to starting work. 
Alternatively, a facility may consider having HCP report temperature and absence of symptoms to occupational health 
prior to starting work. Modes of communication may include telephone calls or any electronic or internet-based means 
of communication. 
Occupational health or infection control personnel should establish points of contact between the organization, the self-
monitoring personnel, and the local or state health departments of authority in the location where self-monitoring 
personnel will be during the self-monitoring period. This communication should result in agreement on a plan for 
medical evaluation of personnel who develop fever or symptoms of COVID-19 (e.g., cough, shortness of breath, sore 
throat, myalgias, malaise) during the self-monitoring period. The plan should include instructions for notifying 
occupational health and the local public health authority, and transportation arrangements to a designated hospital, if 
medically necessary, with advance notice if fever or symptoms of COVID-19 occur. The supervising organization should 
remain in contact with HCP through the self-monitoring period to manage self-monitoring activities and provide timely 
and appropriate follow-up if symptoms occur in a HCP. Note, inter-jurisdictional coordination will be needed if HCP live 
in a different local health jurisdiction than where the healthcare facility is located. 
Close contact for healthcare exposures is defined as follows: a) being within approximately 6 feet (2 meters) of a person 
with COVID-19 for a prolonged period of time (such as caring for or visiting the patient; or sitting within 6 feet of the 
patient in a healthcare waiting area or room); or b) having unprotected direct contact with infectious secretions or 
excretions of the patient (e.g., being coughed on, touching used tissues with a bare hand). 
Data are limited for definitions of close contact. Factors for consideration include the duration of exposure (e.g., longer 
exposure time likely increases exposure risk), clinical symptoms of the patient (e.g., coughing likely increases exposure 
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risk) and whether the patient was wearing a cloth face covering or facemask (which helps block respiratory secretions 
from contaminating others and the environment), PPE used by personnel, and whether aerosol generating procedures 
were performed. 
Data are insufficient to precisely define the duration of time that constitutes a prolonged exposure. However, until more 
is known about transmission risks, it is reasonable to consider an exposure greater than a few minutes as a prolonged 
exposure. Brief interactions are less likely to result in transmission; however, clinical symptoms of the patient and type 
of interaction (e.g., did the patient cough directly into the face of the HCP) remain important. Recommendations will be 
updated as more information becomes available. 
Risk stratification can be made in consultation with public health authorities. Examples of brief interactions include: 
briefly entering the patient room without having direct contact with the patient or their secretions/excretions, brief 
conversation at a triage desk with a patient who was not wearing a cloth face covering or facemask. See Table 1 for 
more detailed information. 
Healthcare Personnel: For the purposes of this document, HCP refers to all paid and unpaid persons serving in 
healthcare settings who have the potential for direct or indirect exposure to patients or infectious materials, including 
body substances; contaminated medical supplies, devices, and equipment; contaminated environmental surfaces; or 
contaminated air. For this document, HCP does not include clinical laboratory personnel. 
II. Defining Exposure Risk Category 
 
While body fluids other than respiratory secretions have not been clearly implicated in transmission of COVID-19, 
unprotected contact with other body fluids, including blood, stool, vomit, and urine, might put HCP at risk of COVID-19. 
Table 1 describes possible scenarios that can be used to assist with risk assessment. These scenarios do not cover all 
potential exposure scenarios and should not replace an individual assessment of risk for the purpose of clinical decision 
making or individualized public health management. Any public health decisions that place restrictions on an individual’s 
or group’s movements or impose specific monitoring requirements should be based on an assessment of risk for the 
individual or group. Healthcare facilities, in consultation with public health authorities should use the concepts outlined 
in this guidance along with clinical judgement to assign risk and determine need for work restrictions. 
For this guidance high-risk exposures refer to HCP who have had prolonged close contact with patients with COVID-19 
(beginning 48 hours before onset of symptoms) who were not wearing a cloth face covering or facemask while HCP nose 
and mouth were exposed to material potentially infectious with the virus causing COVID-19. Being present in the room 
for procedures that generate aerosols or during which respiratory secretions are likely to be poorly controlled (e.g., 
cardiopulmonary resuscitation, intubation, extubation, bronchoscopy, nebulizer therapy, sputum induction) on patients 
with COVID-19 (beginning 48 hours before onset of symptoms) when the healthcare providers’ eyes, nose, or mouth 
were not protected, is also considered high-risk. 
Medium-risk exposures generally include HCP who had prolonged close contact with patients with COVID-19 (beginning 
48 hours before onset of symptoms) who were wearing a cloth face covering or facemask while HCP nose and mouth 
were exposed to material potentially infectious with the virus causing COVID-19. Some low-risk exposures are 
considered medium-risk depending on the type of care activity performed. For example, HCP who were wearing a gown, 
gloves, eye protection and a facemask (instead of a respirator) during an aerosol generating procedure would be 
considered to have a medium-risk exposure. If an AGP had not been performed, they would have been considered low-
risk. See Table 1 for additional examples. 
Low-risk exposures generally refer to brief interactions with patients with COVID-19 (beginning 48 hours before onset of 
symptoms) or prolonged close contact with patients (beginning 48 hours before onset of symptoms) who were wearing 
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a cloth face covering or facemask for source control while HCP were wearing a facemask or respirator. Use of eye 
protection in addition to a facemask or respirator would further lower the risk of exposure. 
Proper adherence to currently recommended infection control practices, including all recommended PPE, should protect 
HCP having prolonged close contact with patients infected with COVID-19. However, to account for any inconsistencies 
in use or adherence that could result in unrecognized exposures, HCP should still perform self-monitoring with 
delegated supervision. 
HCP with no direct patient contact and no entry into active patient management areas who adhere to routine safety 
precautions do not have a risk of exposure to COVID-19 (i.e., they have no identifiable risk). 
Currently, this guidance applies to HCP with potential exposure in a healthcare setting to patients with confirmed COVID-
19. However, HCP exposures could involve a person under investigation (PUI) who is awaiting testing. Implementation of 
monitoring and work restrictions described in this guidance could be applied to HCP exposed to a PUI if test results for 
the PUI are not expected to return within 48 to 72 hours. A record of HCP exposed to a PUI should be maintained and HCP 
should be encouraged to perform self- monitoring while awaiting test results. If the results will be delayed more than 72 
hours or the patient is positive for COVID-19, then the monitoring and work restrictions described in this document 
should be followed. 
Table 1: Epidemiologic Risk Classification1 for Asymptomatic Healthcare Personnel Following Exposure to Patients 
with Coronavirus Disease 2019 (COVID-19) or their Secretions/Excretions in a Healthcare Setting, and their Associated 
Monitoring and Work Restriction Recommendations 
The highest risk exposure category that applies to each person should be used to guide monitoring and work restrictions. 
Note:  While respirators confer a higher level of protection than facemasks and are recommended when caring for 
patients with COVID-19, facemasks still confer some level of protection to HCP, which was factored into our assessment 
of risk.      
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Table 1: Epidemiologic Risk Classification1 for Asymptomatic Healthcare Personnel Following Exposure to Patients with 2019 Novel Coronavirus (2019-nCoV) 
Infection or their Secretions/Excretions in a Healthcare Setting, and their Associated Monitoring and Work Restriction Recommendations 
Epidemiologic risk factors Exposure category 
Recommended Monitoring for COVID-19  
(until 14 days after last potential exposure) 
Work Restrictions for Asymptomatic HCP 
Prolonged close contact with a patient with COVID-19 (beginning 48 hours before symptom onset) who was wearing a cloth face covering or facemask (i.e., source 
control) 
HCP PPE: None Medium Active 
Exclude from work for 14 days after last 
exposure 
HCP PPE: Not wearing a facemask or respirator Medium Active 
Exclude from work for 14 days after last 
exposure 
HCP PPE: Not wearing eye protection Low Self with delegated supervision None 
HCP PPE: Not wearing gown or glovesa Low Self with delegated supervision None 
HCP PPE: Wearing all recommended PPE (except 
wearing a facemask instead of a respirator) 
Low Self with delegated supervision None 
Prolonged close contact with a patient with COVID-19 (beginning 48 hours before symptom onset) who was not wearing a cloth face covering or facemask (i.e., no 
source control) 
HCP PPE: None High Active 
Exclude from work for 14 days after last 
exposure 
HCP PPE: Not wearing a facemask or respirator High Active 
Exclude from work for 14 days after last 
exposure 
HCP PPE: Not wearing eye protectionb Medium Active 
Exclude from work for 14 days after last 
exposure 
HCP PPE: Not wearing gown or glovesa,b Low Self with delegated supervision None 
HCP PPE: Wearing all recommended PPE (except 
wearing a facemask instead of a respirator)b 
Low Self with delegated supervision None 
HCP=healthcare personnel; PPE=personal protective equipment 
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aThe risk category for these rows would be elevated by one level if HCP had extensive body contact with the patients 
(e.g., rolling the patient) 
bThe risk category for these rows would be elevated by one level if HCP performed or were present for a procedure likely 
to generate higher concentrations of respiratory secretions or aerosols (e.g., cardiopulmonary resuscitation, intubation, 
extubation, bronchoscopy, nebulizer therapy, sputum induction). For example, HCP who were wearing a gown, gloves, 
eye protection and a facemask (instead of a respirator) during an aerosol generating procedure would be considered to 
have a medium-risk exposure. 
Additional Scenarios: 
• Refer to the footnotes above for scenarios that would elevate the risk level for exposed HCP. For example, HCP 
who were wearing a gown, gloves, eye protection, and a facemask (instead of a respirator) during an aerosol 
generating procedure would be considered to have a medium-risk exposure. 
• Proper adherence to currently recommended infection control practices, including all recommended PPE, should 
protect HCP having prolonged close contact with patients with COVID-19. However, to account for any 
inconsistencies in use or adherence that could result in unrecognized exposures, HCP should still perform self-
monitoring with delegated supervision. 
• HCP not using all recommended PPE who have only brief interactions with a patient regardless of whether 
patient was wearing a cloth face covering or facemask are considered low-risk. Examples of brief interactions 
include:  brief conversation at a triage desk; briefly entering a patient room but not having direct contact with 
the patient or the patient’s secretions/excretions; entering the patient room immediately after the patient was 
discharged. 
• HCP who walk by a patient or who have no direct contact with the patient or their secretions/excretions and no 
entry into the patient room are considered to have no identifiable risk. 
III. Recommendations for Monitoring Based on COVID-19 Exposure Risk 
 
HCP in any of the risk exposure categories who develop signs or symptoms compatible with COVID-19 must contact 
their established point of contact (public health authorities or their facility’s occupational health program) for medical 
evaluation prior to returning to work 
1. High- or Medium-risk Exposure Category 
HCP in the high- or medium-risk category should undergo active monitoring, including restriction from work in any 
healthcare setting until 14 days after their last exposure. If they develop any fever (measured temperature >100.0oF 
or subjective fever) OR symptoms consistent with COVID-19  (e.g., cough, shortness of breath, sore throat, myalgias, 
malaise) they should immediately self-isolate (separate themselves from others) and notify their local or state public 
health authority and healthcare facility promptly so that they can coordinate consultation and referral to a 
healthcare provider for further evaluation. 
 
2. Low-risk Exposure Category 
HCP in the low-risk category should perform self-monitoring with delegated supervision until 14 days after the last 
potential exposure. Asymptomatic HCP in this category are not restricted from work. They should check their 
temperature twice daily and remain alert for symptoms consistent with COVID-19 (e.g., cough, shortness of breath, 
sore throat, myalgias, malaise). They should ensure they are afebrile and asymptomatic before leaving home and 
reporting for work. If they do not have fever or symptoms consistent with COVID-19 they may report to work. If they 
develop fever (measured temperature > 100.0 oF or subjective fever) OR symptoms consistent with COVID-19 they 
should immediately self-isolate (separate themselves from others) and notify their local or state public health 
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authority or healthcare facility promptly so that they can coordinate consultation and referral to a healthcare 
provider for further evaluation. 
On days HCP are scheduled to work, healthcare facilities could consider measuring temperature and assessing 
symptoms prior to starting work. Alternatively, facilities could consider having HCP report temperature and 
symptoms to occupational health prior to starting work. Modes of communication may include telephone calls or 
any electronic or internet-based means of communication. 
3. HCP who Adhere to All Recommended Infection Prevention and Control Practices 
Proper adherence to currently recommended infection control practices, including all recommended PPE, should 
protect HCP having prolonged close contact with patients infected with COVID-19. However, to account for any 
inconsistencies in use or adherence that could result in unrecognized exposures, HCP should still perform self-
monitoring with delegated supervision as described under the low-risk exposure category. 
 
4. No Identifiable risk Exposure Category 
HCP in the no identifiable risk category do not require monitoring or restriction from work. 
 
5. Community or travel-associated exposures 
HCP with community- or travel-associated exposures to COVID-19  should inform their facility’s occupational health 
program that they have had a community or travel-associated exposure. Decisions about restriction from work 
should be made in consultation with the occupational health program. HCP who develop signs or symptoms 
compatible with COVID-19 should contact their established point of contact (public health authorities or their 
facility’s occupational health program) for medical evaluation prior to returning to work. 
 
